Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine the efficacy of Vismodegib drug in treatment of patients with relapsed or refractory B-cell lymphoma or chronic lymphocytic leukemia (CLL).
Epistemonikos ID: b569c4f3cbe9a8fe10579aba74de64636c3f3ea4
First added on: May 11, 2024